ReviewCurrent oncology (Toronto, Ont.)2023

Bispecific T-Cell Engagers and Chimeric Antigen Receptor T-Cell Therapies in Glioblastoma: An Update.

Roa Alsajjan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.